Synergistic HPV Prevention and Cervical Cancer Protection System

Publication ID: 24-11857675_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic HPV Prevention and Cervical Cancer Protection System,” Published Technical Disclosure No. 24-11857675_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857675_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,675.

Summary of the Inventive Concept

A comprehensive system integrating copper-based uterine cervical devices with AI, IoT, blockchain, and nanomaterial technologies to provide enhanced protection against HPV and cervical cancer, while promoting healthy behavior and secure data sharing.

Background and Problem Solved

The original patent disclosed a method for reducing the incidence and prevalence of HPV using a copper-based uterine cervical device. However, this method has limitations, such as the need for manual insertion and replacement, and the lack of real-time monitoring and data analysis. The new inventive concept addresses these limitations by introducing synergistic combinations of technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The system comprises a copper-based uterine cervical device, an AI-powered monitoring module, an IoT-enabled wearable device, a blockchain-based platform, and a nanomaterial-based sensor. The AI-powered monitoring module tracks cervical microbiome modifications and adjusts the device's surface area accordingly. The IoT-enabled wearable device tracks and analyzes user behavior, providing personalized recommendations. The blockchain-based platform securely stores and shares cervical cancer prevention data, incentivizing healthy behavior through a reward system. The nanomaterial-based sensor detects early signs of cervical cancer, providing timely interventions. The system's components work synergistically to reduce the incidence and prevalence of HPV and cervical cancer.

Novelty and Inventive Step

The new claims introduce novel synergistic combinations of technologies, including AI, IoT, blockchain, and nanomaterials, which are not obvious from the original patent. The integration of these technologies provides a new, more powerful system for HPV prevention and cervical cancer protection.

Alternative Embodiments and Variations

Alternative embodiments may include varying the surface area of the copper-based uterine cervical device, using different types of sensors or monitoring modules, or integrating additional technologies, such as machine learning algorithms or natural language processing. Variations may also include adapting the system for use in different populations or settings, such as in low-resource areas or for specific age groups.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare and medical device industries, particularly in the areas of women's health, cancer prevention, and disease management. The system's ability to provide enhanced protection against HPV and cervical cancer, while promoting healthy behavior and secure data sharing, makes it an attractive solution for healthcare providers, insurers, and patients.

CPC Classifications

SectionClassGroup
A A61 A61K9/0039
A A61 A61F6/144
A A61 A61K33/34

Field of Art

Medical device technologies for women's reproductive health, specifically focused on HPV prevention and cervical cancer intervention, involving biomedical engineering, medical device design, and preventative healthcare technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in reproductive health technologies, advanced materials, sensor technologies, and familiarity with emerging digital health platforms. Possesses advanced degree (MS/PhD), understands interdisciplinary technology integration, and has working knowledge of medical device regulatory frameworks

Obviousness Rationale

A PHOSITA would recognize that integrating digital monitoring technologies with existing medical device designs represents a predictable evolution of cervical health interventions. The copper-based uterine device from the source patent provides a clear technological foundation for adding intelligent monitoring and data tracking capabilities. The proposed variations represent logical extensions of existing medical device innovation strategies, utilizing well-established technological domains like AI, IoT, and blockchain to enhance preventative healthcare solutions.

Obvious Combinations & Variations

Source Patent Element
Copper-based uterine cervical device for HPV prevention
PTD Variation
Adding AI-powered monitoring module to track cervical microbiome modifications
Obviousness Reasoning
Integrating sensor and monitoring technologies with medical devices is a known technique in digital health, representing a predictable application of existing technological capabilities
Source Patent Element
Method for reducing HPV incidence in women
PTD Variation
Incorporating IoT-enabled wearable device for behavioral tracking and personalized recommendations
Obviousness Reasoning
Extending medical interventions through personalized digital monitoring represents a standard approach in preventative healthcare technology design
Source Patent Element
Uterine cervical device maintained for 3-5 years
PTD Variation
Blockchain-based platform for secure data management and user incentivization
Obviousness Reasoning
Implementing secure data management systems for medical devices is a predictable solution addressing privacy and longitudinal health tracking requirements
Source Patent Element
Method for modifying cervical microbiome
PTD Variation
Nanomaterial-based sensor for early cancer detection integrated with machine learning algorithms
Obviousness Reasoning
Applying advanced sensing and analytical technologies to medical device design represents a standard approach for enhancing diagnostic capabilities
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857675, a person having ordinary skill in the art would find the technical variations disclosed herein to be obvious extensions of the prior art. The proposed system represents a predictable combination of known technologies applied to an established medical device framework, thereby rendering potential derivative claims obvious and non-patentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,675
TitleMethod for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections